CHI3L1, which has been widely investigated in cell proliferation, differentiation, apoptosis, angiogenesis, inflammation, and extracellular tissue remodeling (18), also had higher levels in patients with HF, ACS, or CCHD. This evidence concerns the gene CHI3L1 and hydrops fetalis.